Investor Presentaiton
Coloplast revenue development by geography and total
Europe
Other Developed Markets
15
9
2
4
6
2
4
5
16
21
12,916
16
10,573
10,820
11,261
8
10,404
6
10
11
3
5
5,775
4,380
4,644
4,785
4,757
18/19
19/20
20/21
21/22
YTD 22/23
18/19
19/20
20/21
21/22
YTD 22/23
FY 21/22 and YTD 22/23 reported growth rates include respectively 8%-pts and 4%-pts
impact from the Atos Medical acquisition
Emerging Markets
FY 21/22 and YTD 22/23 reported growth rates include respectively 6%-pts and 5%-pts
impact from the Atos Medical acquisition
15
15
12
12
10
8
10
10
3
8
2,986
3,080
3,380
3,888
3,113
18/19
19/20
20/21
21/22
YTD 22/23
FY 21/22 and YTD 22/23 reported growth rates include 1%-pts impact from the Atos
Medical acquisition
Revenue (DKKm)
66
Atos Medical part of organic growth since February 1, 2023
Coloplast group
9
4
7
16
11
8
3
5
6
22,579
17,939
18,544
19,426
18,274
18/19
19/20
20/21
21/22
YTD 22/23
FY 21/22 and YTD 22/23 reported growth rates include respectively 6%-pts and 4%-pts
impact from the Atos Medical acquisition
Reported growth (%)
Organic growth (%)
ColoplastView entire presentation